Covid-19 research in reponse to BAA posting
Ended Definitive Contract Awarded Last action
- Contract number
- 75D30120C08150
- Awardee
-
ABT Global LLC UEI C9S1NLQ67626 Part of ABT Global LLC
- Awarding agency
-
CDC Pittsburgh
Centers for Disease Control and Prevention, Department of Health and Human Services
- Obligated
- $83,824,802
Award facts
- Opportunity
-
- Notice of Intent to Sole Source Pre-Solicitation · 75D30120R67987 · Posted Feb 4, 2022
- Contract value 100% obligated
- $83,824,801.82 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Cambridge, MA 02138, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | -$6,123,260 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $12,667,802 | |
| Supplemental Agreement for work within scope | $24,154,058 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $13,275,220 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $15,206,385 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $10,073,812 | |
| Supplemental Agreement for work within scope | $444,772 | |
| Original award | $14,126,013 |
Show all 16
About this award
The Centers for Disease Control and Prevention awarded a $83.8 million cost-plus-fixed-fee definitive contract to ABT Global LLC for COVID-19 research in response to a Broad Agency Announcement, on May 19, 2020, under no set-aside designation.
The originating solicitation describes research on the epidemiology of SARS-CoV-2 in essential response personnel, evaluating the effectiveness of COVID-19 vaccines among essential workers. CDC awarded this contract on a sole-source basis under FAR 6.302-1, citing ABT Global LLC's incumbent role managing existing study sites and surveillance and laboratory systems established under the original 2020 award. Place of performance is Cambridge, MA.
The contract's ultimate completion date is September 30, 2023. Service Contract Inventory reporting shows ABT Global LLC invoiced $24.5 million in FY2021, $23.3 million in FY2022, and $23 million in FY2023. The FY2023 labor footprint included 30.1 FTEs across 62,637 contractor hours. Government-paid blended hourly rates (prime plus subcontractor) rose from $124.65/hr in FY2021 to $115.66/hr in FY2022, then to $366.71/hr in FY2023. In FY2023, ABT Global LLC engaged three subcontractors for 52% of contractor hours.
Quick answers
Who was awarded contract 75D30120C08150?
75D30120C08150 was awarded to ABT Global LLC by CDC Pittsburgh (Centers for Disease Control and Prevention) on May 19, 2020.
How much is contract 75D30120C08150 worth?
The government has obligated $83,824,802 on 75D30120C08150.
Was contract 75D30120C08150 competed?
The extent of competition for 75D30120C08150 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award